Oruka Therapeutics files to sell 8.72M shares of common stock for holders
EST Oruka Therapeutics (ORKA) files to sell 8.72M shares of common stock for holders Published first on TheFly – the ultimate ...
ETF Daily News3d
Oruka Therapeutics (ORKA) and Its Peers Critical Comparison
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Oruka Therapeutics currently has a consensus target price of $43.17 ...
Oruka Therapeutics to Present at Multiple November Investor Conferences
Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque ...
Positive Outlook for Oruka Therapeutics: Promising Developments with ORKA-001
TD Cowen analyst Tyler Van Buren has reiterated their bullish stance on ORKA stock, giving a Buy rating on October 31. Tyler Van Buren has ...
ETF Daily News6d
Analysts Set Oruka Therapeutics, Inc. (NASDAQ:ORKA) Price Target at $43.17
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have earned a consensus rating of “Buy” from the eight ...
Oruka Therapeutics, Inc.: Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical inflection points ORKA-001 non-human primate (NHP) pharmacokinetic and in vitro ...
Strong Growth Potential for Oruka Therapeutics Driven by Robust Financials and Promising Drug Pipeline
LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on ORKA stock, giving a Buy rating today. Sam Slutsky’s rating ...